Dr Duncan McLauchlan

2020

• Ellis, N.et al. 2020. Genetic risk underlying psychiatric and cognitive symptoms in Huntington’s Disease. Biological Psychiatry 87(9), pp. 857-865. (10.1016/j.biopsych.2019.12.010)
• McLauchlan, D. and Robertson, N. P. 2020. Chronic traumatic encephalopathy: quantifying risk and clarifying pathogenesis. Journal of Neurology 267(3), pp. 870-872. (10.1007/s00415-020-09734-2)

2019

• McLauchlan, D.et al. 2019. Insensitivity to loss predicts apathy in Huntington's disease. Movement Disorders 34(9), pp. 1381-1391. (10.1002/mds.27787)

2018

• McLauchlan, D. 2018. Objective assessment of the neuropsychiatric symptoms in Huntington's Disease. PhD Thesis, Cardiff University.
• McLauchlan, D. and Robertson, N. P. 2018. Stem cells in the treatment of central nervous system disease. Journal of Neurology 265(4), pp. 984-986. (10.1007/s00415-018-8818-7)

2017

• McLauchlan, D., Malik, G. A. and Robertson, N. P. 2017. Cerebral amyloid angiopathy: subtypes, treatment and role in cognitive impairment. Journal of Neurology 264, pp. 2184-2186. (10.1007/s00415-017-8608-7)
• van de Zande, N. A.et al. 2017. Clinical characterization of dystonia in adult patients with Huntington's disease. European Journal of Neurology 24(9), pp. 1140-1147. (10.1111/ene.13349)
• McLauchlan, D. and Robertson, N. P. 2017. B cell treatments for multiple sclerosis. Journal of Neurology 264(4), pp. 814-816. (10.1007/s00415-017-8442-y)

2016

• McLauchlan, D. J. and Robertson, N. 2016. Reversing the trend: interventions to treat intracranial haemorrhage associated with anticoagulation. Journal of Neurology 263(7), pp. 1468-1470. (10.1007/s00415-016-8198-9)
• Yvon, C.et al. 2016. Headache and transient visual loss as the only presenting symptoms of vertebral artery dissection: a case report. Journal of Medical Case Reports 10, article number: 105. (10.1186/s13256-016-0893-8)

2015

• McLauchlan, D. J. and Robertson, N. 2015. Refining the phenotype of inborn errors of metabolism. Journal of Neurology 262(10), pp. 2396-2398. (10.1007/s00415-015-7917-y)

2014

• McLauchlan, D. and Robertson, N. 2014. Reducing central nervous system complications associated with the human immunodeficiency virus. Journal of Neurology 261(9), pp. 1842-1845. (10.1007/s00415-014-7466-9)
• Hrastelj, J.et al. 2014. Hypercalcaemia mimicking Huntington's disease: lessons learned from delayed diagnosis. The Journal of the Royal College of Physicians of Edinburgh 44(4), pp. 286-288. (10.4997/JRCPE.2014.407)

2013

• McLauchlan, D. and Robertson, N. 2013. Epigenetics of Huntington's disease. Journal of Neurology 260(11), pp. 2938-41. (10.1007/s00415-013-7158-x)
• McLauchlan, D. and Robertson, N. 2013. Epidemiological aspects of Guillain-Barre syndrome. Journal of Neurology 260(7), pp. 1942-5. (10.1007/s00415-013-7009-9)
• McLauchlan, D. J. and Rosser, A. E. 2013. A systematic review of the behavioural symptoms in Huntington's disease: A cross-sectional and longitudinal approach [Conference Abstract]. Movement Disorders 28(S1), pp. S264-S264. (10.1002/mds.25605)

2012

• Sawhney, I. M., McLauchlan, D. J. and Powell, H. W. R. 2012. Management of acute symptomatic seizures: outline of clinical practice [Conference Abstract]. Journal of Neurology, Neurosurgery & Psychiatry 83(Suppl2), pp. A4-A4. (10.1136/jnnp-2012-304200a.16)
• McLauchlan, D. J. and Robertson, N. 2012. Management of status epilepticus. Journal of Neurology 259(10), pp. 2261-2263. (10.1007/s00415-012-6673-5)
• Powell, R. and McLauchlan, D. J. 2012. Acute symptomatic seizures. Practical Neurology 12(3), pp. 154-165. (10.1136/practneurol-2012-000244)

2009

• Ramsden, C., Bromage, D. and McLauchlan, D. J. 2009. Evaluating an evidence-based approach to learning physical examination. Medical Education 43(11), pp. 1094-1095. (10.1111/j.1365-2923.2009.03463.x)
• Bromage, D. I., McLauchlan, D. J. and Nightingale, A. K. 2009. Do cardiologists and cardiac surgeons need ethics? Achieving happiness for a drug user with endocarditis. Heart 95(11), pp. 885-887. (10.1136/hrt.2008.163782)